CHICAGO — In patients with acute MI who underwent PCI, spironolactone did not improve the primary composite outcomes but was linked to reduced risk for new or worsening HF, according to new data from the CLEAR SYNERGY (OASIS-9) trial. As Healio previously reported, CLEAR SYNERGY (OASIS-9) was a 2×2 factorial trial in which patients with acute MI who underwent PCI were randomly assigned
Recent studies suggest that intramyocardial adipose tissue facilitates ventricular tachycardia (VT) in subjects with coronary artery disease (CAD) and prior myocardial infarction (MI) scar.1-2 We…
CHICAGO — Reconditioned cardiac devices could help meet an overwhelming need outside of the United States.In a new study presented at the American Heart Association…
Influenza can trigger acute myocardial infarction (AMI) and exacerbate heart failure. Influenza vaccination can prevent these events and is recommended by the American Heart Association…
This randomized clinical trial investigates if behavioral nudges delivered electronically that highlight the cardiovascular benefits of vaccination improve influenza vaccine uptake in patients with acute…
In the era of globalization, medical practices remain influenced by local norms, affecting cultural, financial, and medical dimensions. Pain management is vital in postprocedural care,…
CHICAGO — Exenatide, an IV GLP-1 receptor agonist, did not improve clinical outcomes compared with placebo in patients undergoing heart surgery, according to the results…
WASHINGTON — Withholding Janus kinase or interleukin-17 inhibitors from patients with rheumatoid arthritis or spondyloarthritis does not significantly benefit COVID-19 booster response, according to data…
The AHA now offers a multi-journal submissions system, where authors can submit their papers to multiple AHA journals simultaneously. This system is currently available for…
CHICAGO — Among adults living in India with elevated BP, three different dual-medication polypills containing combinations of recommended first-line antihypertensive agents effectively lowered ambulatory BP,…
Houston Methodist physicians will join experts from around the globe at the American Heart Association’s Annual Scientific Sessions present the latest cutting-edge research in heart…
